T1DM - TYPE 1 DIABETES MELLITUS
Clinical trials for T1DM - TYPE 1 DIABETES MELLITUS explained in plain language.
Never miss a new study
Get alerted when new T1DM - TYPE 1 DIABETES MELLITUS trials appear
Sign up with your email to follow new studies for T1DM - TYPE 1 DIABETES MELLITUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New app could help kids with diabetes get the right insulin dose every time
Disease control Recruiting nowThis study is testing a digital tool that helps children under 12 with type 1 diabetes calculate their insulin doses. The tool considers factors like carbohydrate intake and current blood sugar levels. Researchers will compare blood sugar control over 6 months between children us…
Matched conditions: T1DM - TYPE 1 DIABETES MELLITUS
Phase: NA • Sponsor: Sultan Qaboos University • Aim: Disease control
Last updated Jun 22, 2026 12:01 UTC
-
Could a weekly injection free people with type 1 diabetes from carb counting?
Disease control Recruiting nowThis study tests whether tirzepatide, a weekly injection already used for type 2 diabetes, can help adults with type 1 diabetes use an automated insulin pump without needing to count carbohydrates at meals. About 105 participants will be randomly assigned to receive tirzepatide o…
Matched conditions: T1DM - TYPE 1 DIABETES MELLITUS
Phase: PHASE2, PHASE3 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 18, 2026 11:52 UTC
-
New drug aims to control type 1 diabetes early
Disease control Recruiting nowThis study tests a new drug, CNP-103, in people aged 12 to 35 who were diagnosed with stage 3 type 1 diabetes within the last 6 months. The goal is to see if the drug is safe and can help control the disease. Participants will receive either the drug or a placebo, and researchers…
Matched conditions: T1DM - TYPE 1 DIABETES MELLITUS
Phase: PHASE1, PHASE2 • Sponsor: COUR Pharmaceutical Development Company, Inc. • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
Pig cell transplant trial aims to stop severe low blood sugar in type 1 diabetes
Disease control Recruiting nowThis early-phase study tests a new treatment called OPF-310, which uses pig islet cells enclosed in a protective capsule, for people with unstable type 1 diabetes who still experience severe low blood sugar episodes despite using an automated insulin pump and continuous glucose m…
Matched conditions: T1DM - TYPE 1 DIABETES MELLITUS
Phase: PHASE1, PHASE2 • Sponsor: Otsuka Pharmaceutical Factory, Inc. • Aim: Disease control
Last updated Jun 10, 2026 13:35 UTC
-
Could engineered immune cells free type 1 diabetes patients from insulin?
Disease control Recruiting nowThis early study tests a new treatment for people with early-stage type 1 diabetes. The therapy uses specially engineered immune cells (CAR-T cells) from a donor to target and calm the immune attack that destroys insulin-making cells. The goal is to see if it is safe and can help…
Matched conditions: T1DM - TYPE 1 DIABETES MELLITUS
Phase: EARLY_PHASE1 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 09, 2026 12:07 UTC